Kwame Owusu-Edusei

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Vaccines

Infectious diseases and therapy

Tuberculosis research and treatment

Journal of medical economics

Centers for Disease Control and Prevention

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centers for Disease Control and Prevention

United States

Economist

Merck and Co Inc West Point Aug 19 2019

United States

Principal Scientist :: CORE-EDS

Publications

Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy 13 (5) (2024)
Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy (2024)
Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy 13 (5) (2024)
Ibrahim Diakite, Bruno Martins, Kwame Owusu-Edusei, Palmer Cody, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Ryan B Simpson, Vincent J Daniels, Elamin H Elbasha
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts. Infectious diseases and therapy 13 (5) (2024)
Min Huang, Tianyan Hu, Jessica Weaver, Kwame Owusu-Edusei, Elamin H Elbasha
Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population. Vaccines 11 (1) (2023)
Min Huang, Tianyan Hu, Jessica Weaver, Kwame Owusu-Edusei, Elamin H Elbasha
Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population. Vaccines 11 (1) (2023)
Min Huang, Tianyan Hu, Jessica Weaver, Kwame Owusu-Edusei, Elamin H Elbasha
Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population. Vaccines 11 (1) (2023)
Vincenzo Restivo, Vincenzo Baldo, Laura Sticchi, Francesca Senese, Gian Marco Prandi, Linde Pronk, Kwame Owusu-Edusei, Kelly D Johnson, Tim Ignacio
Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness. Vaccines 11 (7) (2023)
Tianyan Hu, Thomas Weiss, Goran Bencina, Kwame Owusu-Edusei, Tanaz Petigara
Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries. Journal of medical economics 24 (1) (2021)
Kwame Owusu-Edusei, Carla A Winston, Suzanne M Marks, Adam J Langer, Roque Miramontes
Tuberculosis Test Usage and Medical Expenditures from Outpatient Insurance Claims Data, 2013. Tuberculosis research and treatment 2017 (2017)

Kwame Owusu-Edusei.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kwame Owusu-Edusei